// App-Quantinova.ai

3261 : Nanobody Based Tri-Specific Chimeric Antigen Receptor to Treat Acute Myeloid Leukaemia

Researchers

Presenter

  • Warren Hazelton

Principal Investigators

  • Sara Ghorashian

  • Martin Pule

Medical Centers

  • Institute of Neurology, University College London, London, United Kingdom

  • Nephrology Unit, Developmental Biology and Cancer Program, UCL Great Ormond Street Institute of Child Health, London, United Kingdom

  • Bart's Cancer Institute, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Cluster of differentiation 8A

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin-2

  • T-cell function

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved